SCHEMBL22373677

SCHEMBL22373677

Cc1cccc(-c2nc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)nc(-c3cc(-c4ccccc4)cc(-c4ccc(Cc5cccc(-c6nc(-c7cccc(-c8ccccc8)c7)nc(-c7cccc(-c8ccccc8)c7)n6)c5)cc4)c3)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.53
▸ NPC1 O15118 4/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ TDP1 Q9NUW8 4/20 0.47
▸ MAPK1 P28482 3/20 0.47
▸ TSHR P16473 1/20 0.47
▸ LTA4H P09960 1/20 0.46
▸ NR1I3 Q14994 1/20 0.45
▸ PTPN5 P54829 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ DPP4 P27487 1/20 0.41
▸ ACMSD Q8TDX5 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ IDH1 O75874 1/20 0.40
▸ TRPV1 Q8NER1 1/20 0.40
▸ MGLL Q99685 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20091333 0.85 KMT2A (0.52) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL20156908 0.84 NPC1 (0.54) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL24403747 0.84 L3MBTL1 (0.52) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL10052472 0.84 RAB9A (0.59) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL19007466 0.82 RAB9A (0.58) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL18267907 0.82 RAB9A (0.58) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL15588093 0.82 RAB9A (0.61) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL23615502 0.82 RAB9A (0.48) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL4546958 0.81 RAB9A (0.49) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A
SCHEMBL4546937 0.81 RAB9A (0.56) RAB9ANPC1SMN1; SMN2L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773320-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-03 — — US disclosed
US-20200274076-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2020-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773320-B2 Organic electroluminescent materials and devices CCNL2, HCN4, HNRNPL RAB9A 2154/4885NPC1 4398/4885SMN1; SMN2 1917/4885
US-20200274076-A1 Organic Electroluminescent Materials and Devices CCNL2, HCN4, HNRNPL RAB9A 2140/4885NPC1 4274/4885SMN1; SMN2 1888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback